highly diffusible, and short-lived, NO represents the first of a novel class of mammalian inter-and intracellular messenger molecules.
Its biological actions range from signal transduction to cell killing and neurodegeneration. The molecular mechanisms that lead to its double-edged biological role are not fully understood.
Low biophase concentrations of NO ( 2 M) and discontinuous, Ca2-regu1ated formation and release seem to mainly subserve messenger functions with the heme protein soluble guanylyl cyclase as a major molecular target (3, 4) . Within the central nervous system, NO has been suggested to be involved in synaptic plasticity of the mature brain, such as long-term potentiation (5-7) and long-term depression (8), as well as in synaptogenesis of the developing brain (9, 10). To make use of NO as a neuronal messenger molecule and avoid its neurotoxic potential, tight regulation of its biosynthesis is crucial.
At least three distinct isozymes and corresponding genes of NO synthase (NOS; L-arg nine, NADPH:oxygen oxidoreductase [nitric oxide-forming], E.C. 1.14.13.39) exist (1). In neurons, the most abundant isoform of NOS is type I (NOS-I or ncNOS, also termed nNOS in ref 11), which has a cDNA-predicted molecular mass of 160 kDa (12, 13) and migrates on SDS-PAGE with an apparent molecular mass of 155 kDa (NOS-liss; ref 14) . The key regulatory molecule of electron flow within all NOS isoforms (15, 16 ) is the Ca2"-binding protein calmodulin (14, 17, 18) , which binds to different NOS isoforms in either a Ca2"-dependent (NOS-I and III) or Ca2"-independent (NOS-Il) manner. NOSs are further differentiated by their mode of expression (19) , which is termed either constitutive (NOS-I and III) or inducible (NOS-JI). Several other regulator mechanisms have been suggested for NOS-I based on in vitro findings (20, 21) ; however, none has been elucidated at the molecular level and shown to be of physiological relevance. Thus, [Cal+] i remains the only established in vivo regulator of neuronal NO formation.
In light of the suggested role for NO in synaptogenesis (9, 10), we sought to investigate the developmental regulation of NOS-1155, which may also be of relevance for nonneuronal functions of NOS-I (2). We here demonstrate the physiologic postnatal induction of NOS-1155 during rodent brain development with maxima and a temporal and spatial pattern that correlates with synaptogensis. 
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over, two putative transient variants of NOS-I may further contribute to the regulation of neuronal NO formation.
METHODS

Materials
The materials used in this study were obtained from the following sources:
FAD J.tM H4biopterin, up to 50 J.tM L-arginine, 0.22 nM L-[2,3,4,5-3H]arginine, 1 mM NADPH, 7 mM GSH, pH 7.0) for 30 mm at 37#{176}C in a total volume of 100 J.tl. To some reactions, either 2 mM EGTA, to test for Ca2"-independent NOS activity, or different concentrations of the NOS inhibitor NO2Arg (26) were added. The reactions were stopped by addition of 900 Ltl of slop buffer (20 mM sodium acetate, 2 mM EDTA, pH 5.5) and the total volume of 1 ml was then applied to a 0.8 ml cation exchange column Dowex AG 50 WX-8, Na" form) equilibrated with 2 ml of stop buffer.
H-labeled citrulline was eluted twice with 1 ml of water and the radioactivity in the combined flow-through and eluate (3 ml) was measured by liquid scintillation counting. Each result is shown as the mean of n = 3 experiments ± the standard error of mean (vertical bars). The limit of detection was 1.49 pmol L-citrulline.
Protein determination
Protein concentrations were determined in triplicate according to Bradford (27) using bovine serum albumin as a standard.
SDS-PAGE, Western blotting, and densitometry
Synaptosomal and cytosolic fractions of fetal brains and postnatal cerebral neocortex (100 JIg protein/lane) were separated by 1-dimensional SDS.-PAGE under reducing conditions using 7.5% gels (28) and then electroblotted to nitrocellulose membranes using a semidry transfer method (29). Protein blots were blocked for 12 h at 4#{176}C in Tris-buffered saline (TBS; 20 mM Tris.HC1, pH 7.5, 200 mM NaCl) containing 3 g/100 ml chicken egg albumin. NOS-I immunoreactive proteins were detected using anti-NOS-I (batch 6763-5, ref 14; 1:3000 in TBS, overnight, 4#{176}C,), followed by horseradish peroxidase-coupled goat polyclonal antibody directed against rabbit immunoglobulin (Sigma, Deisenhofen, Germany; 1:5000 in TBS, 1 h, room temperature). Between each step, blots were washed five times in TBS. They were developed and immune complexes were visualized using an enhanced chemiluminescence procedure as described (14) with a limit of detection for 125 ng NOS-I. Blots were further subjected to densitometric scanning using a Molecular Dynamics densitometer or flatbed laser scanner coupled to digital analysis software (PDI Inc., Huntington Station, N. Y.; NIH Image). The densities of the 144 and 155 kDa-NOS-l immunoreactive protein bands were quantitated as peak area over background, standardized to the peak area observed at 
Isolation of total
RESULTS
Induction of NOS-1155
After subcellular fractionation of late postnatal and adult brain tissue homogenates, NOS-I immunoreactivity migrated with an electrophoretic mobility equivalent to 155 kDa (NOS-liss; Fig. 1 ). NOS activity indicative of the type I isoform, i.e. Ca2-dependent and soluble (22) , was recovered from both the crude cytosolic and synaptosomal fractions ( Fig. 1 and Fig. 2 ). Ca2"-independent NOS activity was not detected. The ratio between cytosolic and synaptosomal NOS-I activity was between 6.2:1 (P20) and 104:1 (P60) in rat neocortex, and it was 5.4:1 (P60) in mouse cerebellum.
When assayed in the presence of saturating concentrations of cofactors and calmodulin, NOS activity in both brain regions was dependent on free Ca2" levels. However, during embryonic stages of cortical as well as cerebellar development, neither NOS-1155 immunoreactivity nor NOS activity was expressed ( Fig. 1 and Fig. 2) . Rather, NOS-1155 expression commenced sharply after birth (P0) both in the crude cytosolic and synaptosomal fractions. The induction of NOS-1155 protein expression and NOS activity was particularly pronounced in the synaptosomal fraction, thus lowering the ratios of NOS activity in the crude cytosolic and synaptosomal fractions to 0.56:1 in rat neocortex and to 3.6:1 in mouse cerebellum.
In the cerebellum, where specific cell types can be reliably identified, NOS-1155 expression was morphologically confined to the same cell types, i.e., granule cells and stel- June 1995
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late/basket neurons, throughout postnatal development (Fig. 3) . P2 and P9 in rat neocortex and between P12 and P20 in mouse cerebellum (see Fig. 1 and Fig. 2) . In a second phase, which began between P12 and P15 in rat neocortex and between P20 and P60 in mouse cerebellum, specific NOS activity decreased again-predominately in the synaptosomal fractions-whereas cytosolic activity values remained constant until P60 in rat neocottex. This time course of NOS expression corresponded well to the NOS-1155 immunoreactivity as detected by Western blot analysis.
Immunocytochemical staining of cerebella was used to verify the cellular localization of NOS-! during development. NOS-I expression was restricted to granule cells and basket/stellate neurons ( Fig. 3 ; see also to ref 33). Endotheha of blood vessels that cover the surface of the cortex (upper margin of both panels in Fig. 3 ) and express NOS-IlI were immunonegative, demonstrating again the specificity of the antiserum for NOS-l. Early in cerebellar development (P8), NOS-I immunoreactivity was seen in granule cells in the internal granule cell layer and in the nascent molecular layer containing the axons (parallel fibers) of postmigratory granule cells. Granule cell precursors and premigratory granule cells in the external granule cell layer and the Purkinje cell layer were immunonegative.
In the adult cerebellar cortex (P60), the molecular layer and the granule cell layer remained intensely immunostained. However, during the second postnatal week and continuing into adulthood distinct differences in the staining intensity of granule neurons became apparent (i.e., subsets of granule cells arranged in discrete clusters) and maintained a high level of NOS-I immunoreactivity, whereas other granule cells, again grouped together in clusters, no longer stained for NOS-I or stained only very faintly (compare the patchy staining pattern of the granule cell layer in Fig. 38 to the rather homogenous staining of this layer in Fig. 3A ; for further details, see ref 33).
NOS.I variants
In embryonal rat neocortex, a NOS-I-immunoreactive protein was expressed with an electrophoretic mobility (SDS-PAGE) equivalant to an apparent molecular mass of 144 kDa (NOS-Iiw; see Fig. 1 ). On the other hand, NOS-1155 immunoreactivity or any other anti-NOS-I cross-reactive protein, in particular low molecular weight proteolytic fragments, were not detected. Tissue homogenates of the same age that clearly contained a NOS-Iiw immunostaining band, e.g., at E19, were devoid of NOS activity (see Fig. 1 ). We investigated whether the appearance of the NOS-Ii-immunoreactive protein correlated with the transcription of alternatively spliced NOS-I mRNA similar to mouse nNOS-2 mRNA lacking a 315 bp in frame deletion. Rat neocortex total RNA was isolated at different developmental stages and analyzed by RT-PCR. Primers specific for rat NOS-I were designed to discriminate by size between nNOS-1 and the respective in frame-deleted nNOS-2 transcripts (11). However, the same amplification products (about 700 bp) were detected at all time points in embryonal and postnatal neocortex (Fig. 4) . This value corresponded well to the theoretical amplification product of 692 bp calculated from the full-length rat NOS-I eDNA sequence (base 1315 to 2007). Thus, at all developmental stages nNOS-2 mRNA was below the detection limits of the RT-PCR method. Using additional primers spanning the entire NOS-I reading frame, all amplification products at all time points corre- sponded to the full-length transcripts of nNOS-1 mRNA (data not shown).
NOS-I activity assayed in the presence of saturating concentrations of L-arginine in both neocortex and cerebellum was concentration-dependently inhibited by NO2Arg (Fig.  5) . The concentration response curves for 0. 1 jiM NO2Arg were superimposable at all developmental days tested (1C50
jiM at 10 jiM L-arginine). However, during a small time window between PS and P9 (maximal at P7) of mouse cerebellum, the inhibition curve of NOS activity by NO2Arg became biphasic. This was apparently due to an increase in sensitivity towards NO2Arg (1C50 < 10 nM) of a fraction of 32% of total NOS activity during this time.
DISCUSSION
The activity of the so-called constitutive NOS-I/ncNOS (1, 19) is regulated short-term by [Ca2] (17, 34). Our findings provide new evidence that, in vivo, NOS-I expression and possibly activity are regulated long-term by several mechanism in different brain regions. The expression of neuronal NOS-1155 correlates with synaptogenesis and is fully compatible with the hypothesis (9) and recent data suggesting a functional role for NO in brain development (10) and synaptic plasticity (8). Moreover, our data may have implications for nonneuronal functions of NO (2). Expression of NOS-I has also been reported in the PC-12 pheochromocytoma cell line upon induction of a neuronal phenotype by nerve growth factor (35). However, in embryonic and early postnatal brain (i.e., at a time point when many neuron-specific functions and marker proteins are
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already expressed), we were not able to detect NOS-1155 as defined by enzyme activity, subcellular localization, electrophoretic mobility (155 kDa; ref 22) , or immunoreactivity although NOS-I mRNA was present. The delayed postnatal expression of NOS-155 protein and activity in different brain regions was, therefore, specific and also revealed a complex biphasic time course. The sharp early-postnatal peaks of NOS-1155 protein and activity in the synaptosomal fractions of P2 to P9 rat neocortex and P15 mouse cerebellum suggest that, in addition to [Ca2}, NO formation in neurons and synaptic terminals is regulated by NOS-1155 expression.
The different time courses of regional NOS-I induction effectively rule out systemic mechanisms, e.g., maternal circulating hormones, but rather parallel the characteristic onset times of synaptogenesis in cerebellum (36, 37) and, 1 wk earlier, in neocortex (38-41).
The relative distribution of NOS-1155 between the crude cytosolic and crude synaptosomal fraction and its regulation suggests a preferential location of NOS-I in synaptic terminals during synaptogenesis.
However, similar to NOS-ilI (42), NOS-I may also be shifted between the crude cytosolic and membrane fraction. Our data are consistent with the hypothetical role of NO in synaptogenesis as suggested by Gaily et al. During a second postnatal phase of NOS-I expression, the overall levels of NOS-1155 protein and NOS activity were decreased to about 30-55% of the maxima reached during synaptogenesis, both in cerebellum and neocortex. This was due to a preferential decrease of NOS-I155 protein and activity in synaptosomes.
It will be of interest to study aged animals to establish whether the cytosolic NOS-1155 expression in adult animals remains constant or declines with age. Immunocytochemical analysis in cerebellum up to P60 revealed that the decline in NOS activity in tissue extracts was not only due to a uniform reduction of synaptosomal enzyme levels in all NOS-I positive neurons, but also involved cell clustering.
Although the NOS-I immunoreactivity in some clusters appeared unchanged or even slightly increased when compared to their P15-levels, others became almost completely negative for NOS-I. Transiently NOS-immunopositive or NADPH diaphorase-positive neurons were also observed in the rat cerebral cortical plate, sensory ganglia, and olfactory epithelium (43 
